Current role
Heather Rees
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Heather Rees
Atossa Therapeutics, Inc. reported in an 8-K filed July 2, 2024 that Heather Rees was appointed Chief Financial Officer, effective June 27, 2024. The proxy statement of Atossa Therapeutics, Inc. reports total compensation of $981,724 for Heather Rees in fiscal 2025, including a base salary of $482,217. Disclosed compensation is on record for 3 fiscal years.
“On June 27, 2024, the Board of Directors (the "Board") of the Company appointed Heather Rees, previously the Company's Senior Vice President, Finance and Accounting, to serve as Chief Financial Officer and to continue serving as principal financial and accounting officer, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Atossa Therapeutics, Inc. (ATOS)
Proxy statement
CurrentStart not stated–present
-
Start not stated–2025-03-26
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Atossa Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Steven Quay CEO
- Greg Weaver CFO
- Mark Daniel CFO, Chief Accounting Officer
- Mark J. Daniel CFO
- Dr. Tessa Cigler, M.D., M.P.H. Board Member
- H. Lawrence Remmel, Esq. Board Member
- Jonathan Finn Board Member
- Jonathan Finn, CFA Board Member
- Shu-Chih Chen Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Atossa Therapeutics, Inc. (ATOS) | CPA (Inactive) | $482,217 | $981,724 |
| 2024 | Atossa Therapeutics, Inc. (ATOS) | CPA (Inactive) | $402,487 | $1,149,674 |
| 2023 | Atossa Therapeutics, Inc. (ATOS) | CPA (inactive) Finance and Accounting | $331,585 | $687,463 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.